Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies. But ...

By Nancy Lapid April 17 (Reuters) - Researchers have developed a modified version of the CRISPR gene-editing tool that in early laboratory experiments suggests it may have the potential to “silence” ...

One of the most studied lifespan-extending drugs in animals has just failed its test on humans in a 13-week clinical trial co ...

Charli xcx's latest project is a surprisingly intimate character drama, made in close collaboration with a boundary-pushing ...

Pioneering artist, Pinar Demirdag, shares lessons from being the first creative professional made obsolete by AI—and how that ...

This roundup highlights the latest robotics innovations aimed at improving throughput, simplifying deployment and helping ...

A new clinical trial is enrolling up to 60 children and young people with solid tumors across the United States and United ...

A new milestone in industrial AI is unfolding on the factory floor. Siemens, working alongside NVIDIA and UK-based robotics firm Humanoid, has successfully deployed a humanoid robot inside a live ...

But delivering these treatments safely and precisely to the right cells remains a major hurdle—especially in hard-to-target organs like the brain and kidneys. Now, researchers led by a University of ...